ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
123.779,54
-0,58%
S&P 500
5.306,04
0,02%
US Dollar vs BRL
5,1631
-0,20%
Bitcoin
68.350,23
-1,50%
Brent Oil
84,325
1,79%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Carisma Therapeutics Inc (CARM)

  7. Carisma Therapeutics Inc (CARM) Notícias

CARM Carisma Therapeutics Inc

1,34
-0,01 (-0,74%)
Após o horário de negociação
Última atualização: 19:14:32
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Carisma Therapeutics Inc CARM NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
-0,01 -0,74% 1,34 19:14:32
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,33 1,27 1,35 1,34 1,35
mais cotações »

Notícias Recentes

Data Hora Fonte Título
16/05/202408:30PRNUSCarisma Therapeutics Announces First Patient Dosed in Phase..
09/05/202408:30PRNUSCarisma Therapeutics Reports First Quarter 2024 Financial..
08/05/202412:45BWCarmila: Withdrawal of funds for the liquidity contract
08/05/202408:30PRNUSCarisma Therapeutics Presents Preclinical Proof of Concept..
07/05/202412:45BWCARMILA: Information Concerning the Total Number of Voting..
06/05/202408:30PRNUSCarisma Therapeutics to Participate in The Citizens JMP Life..
02/05/202408:30PRNUSCarisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief..
24/04/202418:05PRNUSCarisma Therapeutics Announces Upcoming Presentation at the..
24/04/202413:43BWCarmila : Lancement d’un programme de rachat d’actions pour..
22/04/202417:35PRNUSCarisma Therapeutics to Present New Data at the American..
17/04/202412:45BWCarmila: First-quarter 2024 Financial Information
05/04/202412:45BWCarmila : Informations relatives au nombre total de droits..
03/04/202408:00PRNUSCarisma Therapeutics to Present at Upcoming Conferences
01/04/202409:35PRNUSCarisma Therapeutics Provides Business Update and Reports..
01/04/202408:00PRNUSCarisma Therapeutics Announces Changes to its Board of..
21/03/202418:00PRNUSCarisma Announces Upcoming Presentations at the American..
15/03/202413:45BWCARMILA : INFORMATION RELATIVE A LA REMUNERATION DES..
08/03/202413:45BWCORRECTING and REPLACING: Carmila: Changes in the..
07/03/202415:13BWCARMILA: Changes in the composition of the Board of..
04/03/202413:45BWCarmila: Information Concerning the Total Number of Voting..
28/02/202409:30PRNUSCarisma Therapeutics to Participate in TD Cowen's 44th..
13/02/202413:45BWCarmila: 2023 Annual Results
02/02/202413:45BWCARMILA: Information Concerning the Total Number of Voting..
16/01/202413:45BWCarmila: Resources Devoted to the Liquidity Contract as of..
08/01/202413:57BWCARMILA: Information Concerning the Total Number of Voting..
21/12/202309:00PRNUSCarisma Therapeutics to Present at the 42nd Annual J.P...
14/12/202309:00PRNUSFirst In Vivo CAR-M Lead Candidate Nominated Under..
05/12/202313:45BWCarmila : Informations relatives au nombre total de droits..
28/11/202309:00PRNUSCarisma Therapeutics Announces FDA Clearance of IND..
22/11/202309:30PRNUSCarisma Therapeutics to Participate in Evercore ISI..
10/11/202316:17BWCarmila: Termination of Liquidity Contract With BNP Paribas..
09/11/202313:45BWCARMILA : Informations relatives au nombre total de droits..
09/11/202309:30PRNUSCarisma Therapeutics Reports Third Quarter 2023 Financial..
31/10/202310:25PRNUSCarisma Presents Pre-Clinical Proof of Concept for in vivo..
25/10/202310:11PRNUSCarisma to Present First Results From in vivo CAR-M..
20/10/202312:47BWCarmila: Financial Information as of 30 September 2023
02/10/202313:35BWCarmila : Emission d’un emprunt obligataire de 500 millions..
02/10/202312:45BWCARMILA : Informations relatives au nombre total de droits..
05/09/202309:30PRNUSCarisma Therapeutics to Present at Upcoming Investor..
01/09/202312:45BWCARMILA: Information Concerning the Total Number of Voting..
01/09/202309:30PRNUSCarisma Announces Latest Data from Phase 1 Clinical Trial of..
24/08/202309:30PRNUSCarisma Therapeutics to Present at Upcoming Healthcare..
10/08/202314:44PRNUSCarisma Therapeutics Reports Second Quarter 2023 Financial..
03/08/202312:45BWCarmila: Asset Sale in France for €35 Million
01/08/202312:55BWCARMILA : Informations relatives au nombre total de droits..
25/07/202313:52BWCarmila: 2023 Half-Year Financial Report Available
25/07/202312:45BWCarmila: 2023 Half-Year Results
12/07/202313:59BWCarmila: Agreement to acquire Galimmo SCA
07/07/202312:50BWCarmila : Moyens portés au contrat de liquidité au 30 juin..
04/07/202312:51BWCARMILA: Information Concerning the Total Number of Voting..

Seu Histórico Recente

NASDAQ
CARM
Carisma Therapeutics
TSXV
FARM.WT
Deveron
BITMOT
2717993
Bot Zc May24 S Eur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados